
Jochen H. Lorch, MD, MS
Advertisement
Articles by Jochen H. Lorch, MD, MS
Advertisement
Latest Updated Articles
Preferred Testing Methods and Treatment OptionsSeptember 21st 2020
LOXO-101 Trial Regimen OverviewSeptember 21st 2020
A 71-Year-Old Woman With NTRK Gene Fusion Thyroid CancerSeptember 21st 2020
NTRK Gene Fusion Thyroid Cancer: Incidence and PrognosisSeptember 21st 2020
Advertisement
Advertisement
Trending on Targeted Onc
1
FDA Does Not Approve Ivonescimab for EGFR-Mutant NSCLC
2
Dr Dasari on Sequencing RLT, Cabozantinib, and Everolimus in NETs
3
Crossover to Bezuclastinib Plus Sunitinib Improves Disease Control in Pretreated GIST
4
FDA Approves Durvalumab-EV Combo, Expanding MIBC Treatment Options
5
